Paul-Ehrlich-Institut

Go to:

Expert Videos

Ex­pert Videos

Expert Video with Professor Klaus Cichutek on the conditional authorisation of COVID-19 vaccines (German only)

Expert video with Professor Klaus Cichutek on the speed with which COVID-19 vaccines can be authorised (German only)

Professor Klaus Cichutek explains: Coronavirus vaccine (German only)

Source: Federal Ministry of Health

Expert Video with Professor Isabelle Bekeredjian-Ding: Suppy Shortages (German only)

Expert Video with Professor Dr Eberhard Hildt, Virologist: Coronavirus (German only)

Expert Video with Dr Dirk Mentzer: Children Need Researched Medicines (German only)

Updated: 29.03.2021

top

Explanatory Videos

Ex­plana­to­ry Videos

Anniversary Video "125 Years of the Paul-Ehrlich-Institut"

The SafeVac App

How are vaccines developed?

Our commitment to biomedicines

The German Haemophilia Register at the Paul-Ehrlich-Institut

(in German)

Updated: 01.06.2021

top

Audios

Au­dios

Original Sound from Professor Klaus Cichutek, President of the Paul-Ehrlich-Institut, on the COVID-19 Vaccine Authorisation in Russia (German only)



Original Sound from Professor Klaus Cichutek - Phases of Vaccine Development (German only)

Updated: 17.09.2020

top

Press Briefings

Press Brief­in­gs

Press Workshop from 24 March 2022: COVID-19 Diagnostics: How Well Do Antigen Tests Detect Omicron? (German only)

Sensitivität der Antigentests gegenüber der Omikron-Variante - Teil 1: Präsentationen (24.03.2022)

Presentation | Professor Klaus Cichutek, Paul-Ehrlich-Institut: Press Workshop - Sensitivity of Antigen Tests to the Omikron Variant (24 March 2022)
Presentation | PD Dr Micha Nübling, Paul-Ehrlich-Institut: Press Workshop - Sensitivity of Antigen Tests to the Omikron Variant (24 March 2022)

Sensitivität der Antigentests gegenüber der Omikron-Variante - Teil 2: Fragen & Antworten (24.03.2022)

Press Briefing from 14 January 2021: Efficacy and safety of licensed mRNA vaccines against COVID-19 (German only)

Wirksamkeit und Sicherheit der zugelassenen mRNA-Impfstoffe gegen COVID-19 (14.01.2021)

Presentation | Prof Klaus Cichutek, Paul-Ehrlich-Institut: COVID-19 vaccine products authorised in Germany and the EU –Quality, safety, and efficacy (14 January 2021) (German only)
Presentation | Dr Brigitte Keller-Stanislawski, Paul-Ehrlich-Institut: COVID-19 vaccine products authorised in Germany and the EU – Safety and efficacy (14 January 2021) (German only)

Press Briefing from 2 October 2020: New Clinical Trial for a COVID-19 Vaccine Authorised in Germany

Recording Press Briefing (German only)

Alternative Link (YouTube) (German only)
Recording Press Briefing 02.10.2020

FAQ | Paul-Ehrlich-Institut Press Briefing (2 October 2020)
Presentation | Professor Dr Klaus Cichutek, Paul-Ehrlich-Institut - Authorisation of a Clinical Trial Phase I of a Vector Vaccine against COVID-19 (2 October 2020)
Presentation | Professor Dr Marylyn M. Addo (UKE Hamburg) / Professor Dr Gerd Sutter (LMU Munich) - MVA-SARS-2-S: DZIF COVID-19 vaccine candidate (2 October 2020)

Press Briefing from 17 June 2020: Another Clinical Trial of a COVID-19 Vaccine approved in Germany

Recording Press Briefing

(German only)

Alternative Link (YouTube) (German only)
Recording Press Briefing 17 June 2020

Presentation | Professor Dr Klaus Cichutek, Paul-Ehrlich-Institut - Authorisation of the second Clinical Trial of a COVID-19 Vaccine in Germany (17 June 2020)
Presentation | Dr Franz-Werner Haas, Dr Mariola Fotin-Mleczek – CureVac - CureVac’s mRNA based Vaccine Candidate against SARS-CoV-2 (17 June 2020)
FAQ | Paul-Ehrlich-Institut Press Briefing (17 June 2020)

Press Briefing from 22 April 2020: Authorisation of the first clinical trial of a COVID-19 vaccine

Recording Press Briefing

Part 1: Presentations (German only)

Recording Press Briefing

Part 2: Questions and Answers (German only)

Alternative links (Youtube)
Recording Press Briefing 22 April 2020 - Part 1 (German only)
Recording Press Briefing 22 April 2020 - Part 2 (German only)

Presentation | Prof. Dr. Klaus Cichutek, Paul-Ehrlich-Institut - Authorisation of the first clinical trial from the perspective of the regulator (22 April 2020)FAQ | Paul-Ehrlich-Institut Press Briefing (22 April 2020)Presentation | Professor Dr Ugur Sahin – BioNTech - BNT162 COVID-19 Vaccines: Development Programme (22 April 2020)

Updated: 25.03.2022

top

Infographics

In­fo­graph­ics

COVID-19 Vaccination Protects Against Severe Disease As of 14.04.2021 Source: Paul-Ehrlich-Institut

Tasks of the Paul-Ehrlich-Institut on the Vaccine Pathway (Vertical Representation)

Tasks of the Paul-Ehrlich-Institut on the Vaccine Pathway - Infographic Source: Paul-Ehrlich-Institut

Tasks of the Paul-Ehrlich-Institut on the Vaccine Pathway (Horizontal Representation)

Image / Video 1 / 6

Tasks of the Paul-Ehrlich-Institut on the Vaccine Pathway - Infographics Scientific Advice Source: Paul-Ehrlich-Institut

Pagination


Flowchart - Procedure in Case of positive Allergy History before COVID-19 mRNA Vaccination

Flowchart Procedure in case of positive allergy history before COVID-19 mRNA vaccination Flowchart Procedure in case of positive allergy history before COVID-19 mRNA vaccination Source: Paul-Ehrlich-Institut / Robert Koch-Institut / AeDA / DGAKI / NORA / DDG

Flowchart - Procedure in case of positive allergy history before COVID-19 mRNA vaccination


Infographic - Viral Hepatitis - from A to E

Viral Hepatitis - from A to E Viral Hepatitis - from A to E Source: Paul-Ehrlich-Institut

Infographic: Viral Hepatitis - from A to E

Updated: 28.07.2022

top